NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research said today that it has granted CA$12.6 million ($12.6 million) to fund new research projects and to buy equipment for research centers in Ontario, including some awards specifically for genomics and biomarker programs.
OICR awarded a total of CA$6 million to 11 research projects covering cancer biology, diagnostics, and treatment. Another CA$6.6 million was awarded to Ontario institutions to buy equipment that will be used in all stages of cancer research, from lab discoveries to clinical trials.
Among the grantees, OICR’s Genomics Platform in Toronto, which uses genome sequencing tools to understand cancer biology, will receive CA$767,000.
In addition, Ottawa Hospital Research Institute will receive CA$353,000 to develop biomarkers that will predict the clinical benefits of cetuximab, a therapy for advanced colorectal cancer.
A researcher at Ottawa Health Research Institute was awarded CA$648,000 to use a genomic approach to validate targets for osteosarcoma.
Another researcher at Sudbury Regional Hospital has received an award of $382,000 to study tumor RNA integrity as a potential biomarker of chemotherapy response in breast cancer patients.